Text Size

Incorporation of Muscle Qualities in Biomechanical Models of the Upper Limbs

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by:
University Hospital, Ghent
ClinicalTrials.gov Identifier:
NCT00284388
First received: January 30, 2006
Last updated: February 13, 2009
Last verified: February 2009
History of Changes
  Purpose

Development of a non-invasive method for the determination of the position of optimal muscle length in the different muscles of the shoulder.

Analysis of the adaptation of the muscle to a new optimal length in patients with a shoulder prosthesis.


Condition Intervention
Shoulder Prosthesis
 Procedure: Simultaneous controlled power measurement
Procedure: Surface EMG measurement

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Incorporation of Muscle Qualities in Biomechanical Models of the Upper Limbs

Further study details as provided by University Hospital, Ghent:

Primary Outcome Measures:
  • Measurement of the optimal length of the muscles of the shoulder

Estimated Enrollment: 20
  Eligibility

Ages Eligible for Study:   40 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Shoulder prosthesis

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00284388

Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Rene Verdonk, MD, PhD University Hospital, Ghent
  More Information

Additional Information:
Website University Hospital Ghent  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: René Verdonk, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00284388     History of Changes
Other Study ID Numbers: 2004/056
Study First Received: January 30, 2006
Last Updated: February 13, 2009
Health Authority: Belgium: Institutional Review Board

ClinicalTrials.gov processed this record on May 23, 2013